NeoPharma Production AB has sponsored the treatment of 47 patients with Parkinson’s disease in four clinical trials in Sweden and Norway using Duodopa or the Duodopa concept of intraduodenal infusion of a levodopa dispersion. An integrated summary of the results is provided in Section 4.1. and individual summaries for each study report and/or publication are provided in Section 4.2. Another 13 patients known to NeoPharma have received treatment with Duodopa on a named-patient basis.
